| COMPOSITION | GLIMEPRIDE 1MG, METFORMIN 850MG(SR), PIOGLITAZONE 7.5MG |
| Packing | 10X10,10X15 |
| Uses | Produces dual check on the progress of diabetes mellitus, Blessed with multiple antidiabetic effects of metformin, Helps preventing cardiovascular manifestation of insulin resistance |
| Indication | 1. RESISTANT DIABETES MELLITUS. 2. PREVENTION OF ASSOCIATED MACROVASCULAR AND MICROVASCULAR COMPLICATIONS. 3.DIABETES WITH OBESITY |
| Key Ingrediants | GLIMEPIRIDE 1MG, METFORMIN 850MG (SR), PIOGLITAZONE 7.5MG |
| PRODUCT DISCRIPTION | This combo tablet of Glimepiride 1 mg, Metformin 850 mg (sustained release), and Pioglitazone 7.5 mg is used to treat type 2 diabetes mellitus, especially in patients whose blood sugar levels are not adequately controlled by diet, exercise, and single or dual oral hypoglycemic agents. Even, this combination uses the complimentary modes of action of the three medications to improve glycemic control. |